Note: Descriptions are shown in the official language in which they were submitted.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
1
TRANSFER HYDROGENATION PROCESS AND CATALYST
The present invention relates to transfer hydrogenation and encompasses
processes for transfer hydrogenation, e.g. for producing optically active
compounds and
catalysts for use in such processes.
Numerous catalysts (generally comprising a transition metal) are known for
effecting transfer hydrogenation. The following disclosures are of relevance.
(1) Noyori et al; J.A.C.S., 1995, 117 7562-7563: which discloses that use of
chloro
ruthenium-mesitylene-N-monotosyl-1,2-diphenylethlyenediamine as catalyst ~ in
the
transfer hydrogenation of acetophenone to 1-phenylethanol by propan-2-of gave
up to a
95% yield of product having 97% entantiomeric excess. Similar results were
obtained
to starting from other alkylaryl ketones.
(2) Noyori et al: J. Chem.Soc.Chem, Commun, .1996, 233-234: which discloses
catalysts similar to those of (1) above but containing other alkylbenzene
ligands and
various beta-amino alcohols in place of diphenylethylenediamine. The preferred
arene
ligand was hexamethylbenzene.
(3) Our earlier W098/42643 which discloses transfer hydrogenation catalysts
incorporating an optionally substituted cyclopentadienyl group co-ordinated or
otherwise
bonded to a metal (e.g. ruthenium, rhodium or iridium) capable of catalysing
transfer
hydrogenation. The hydrogenation of compound containing carbon-carbon, carbon-
nitrogen, carbon-oxygen and carbon-sulphur double bonds is disclosed.
(4) Our earlier WO00/18708 discloses transfer hydrogenation of iminium salts
(including protanated imine salts and quaternary imine salts) using catalysts
of the type
disclosed in (1 ) to (3).
The catalysts used in (1 )-(4) whilst being effective for transfer
hydrogenation have
the disadvantage that they are difficult to recover from the product mixture.
This gives rise to a number of problems. Firstly, the catalysts are relatively
expensive and the fact that at least a portion of the catalysts may not be
recoverable adds
to the expense of the hydrogenation process. Secondly, the fact that catalyst
is present in
the final product may prevent application of the hydrogenation process to the
production
of pharmaceutical and veterinary products since administration of the catalyst
residue to
3o humans or animals is undesirable.
It is therefore an object of the present invention to obviate or mitigate the
abovementioned disadvantage.
According to a first aspect of the present invention there is provided a
process for
the transfer hydrogenation of an organic compound having a carbon-carbon or
carbon
heteroatom double bond, said process comprising reacting said organic compound
with a
hydrogen donor in the presence of a catalyst having the general formula:
CONFIRMATION COPY
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
2
A~ E.\ B
\ /
Y~M~R~s
s in which:
R'$ represents an opfiionally substituted hydrocarbyl or perhalogenated
hydrocarbyl ligand;
A represents -NR'9-, -NR2°-, -NHR'9, -NR'9R2° or -
NR2°R2' where R'9 is H,
C(O)R2', SOZR2', C(O)NR~'R25, C(S)NR2'R25, C(-NR2s)SRz6 or C(=NRzS)OR26,
R2° and
1o Rz' each independently represents an optionally substituted hydrocarbyl,
perhalogenated
hydrocarbyl or an optionally substituted heterocyclyl group, and R25 and Ras
are each
independently hydrogen or a group as defined for R~';
B represents -O-, -OH, OR2a, -S-, -SH, SR~2, -NR22-, -NR23-, -NHR23, -NR2zR23,
-NR2~R~4, -PR22- or -PR~~R24 where R~3 is H, C(O)R24, S02R24, C(O)NR~4R~',
1s C(S)NR24Ra', C(=NR2')SR2$ or C(=NRZ')OR28, R2~ and R24 each independently
represents
an optionally substituted hydrocarbyl, perhalogenated hydrocarbyl or an
optionally
substituted heterocyclyl group, and R2' and R2$ are each independently
hydrogen or a
group as defined for R2a;
E represents a linking group;
2o M represents a metal capable of catalysing transfer hydrogenafiion; and
Y represents an anionic group, a basic ligand or a vacant site;
provided that when Y is not a vacant site that at least one of A or B carries
a
hydrogen atom, characterised in that at least one of said groups RZ° to
R~Z or R24 to R28 is
present in the form of an optionally substituted sulphonated hydrocarbyl
group, a
2s sulphonated perhalogenated hydrocarbyl group, or an optionally substitufied
sulphonated
heterocyclyl group.
According to a second aspect of the present invention there is provided
catalysts
as defined in the preceding paragraph.
As used herein (and unless the context otherwise requires) the term
"sulphonated"
3o is intended to cover the presence of the sulphonic acid moiety (-SO3H) and
salts thereof.
Alkali metal (particularly sodium and potassium) sulphonates are preferred
examples of
sulphonate groups. Furthermore the enhanced solubility of the ligands (as
provided by
the polar sufphonate group) gives rise to the possibility of conducting
hydrogenation
reactions in water, other polar solvents, biphasic systems and in support'
polar phase
3s catalysis. Alternatively, the sulphonate group may be present in the form
of an anhydride
(e.g. partially derived from a CO~H group).
The catalytic species is believed to be substantially as represented in the
above
formula. It may be introduced on a solid support.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
3
The transfer hydrogenation process may for example be conducted as a
homogenous reaction of the type disclosed in (1 ) to (4) above and the
hydrogenated
product obtained by standard make-up procedures such as extracting the product
mixture
with water (e.g. after dilution of the mixture with diethyl ether) and then
drying the organic
layer over, for example, magnesium sulphate followed by filtration and
evaporation of
' solvent.
The presence of the polar sulphonate group does however give rise to the
possibility of effecting the reaction and/or product recovery in various ways.
Thus, for example, at the end of the reaction there may be added to the
product
to mixture an ion exchange resin so that the catalyst becomes immobilised on
the resin by
virtue of its sulphonate group. The product mixture may then be decanted from
the resin
and the product recovered with minimal or no catalyst residue. Accordingly, a
further
aspect of the present invention comprises a process of the first aspect of the
present
invention, further comprising an additional step of adding an ion exchange
resin after
reacting the organic compound with the hydrogen donor in the presence of the
catalyst.
Alternatively the catalyst may be used as a "supported liquid phase catalyst"
which
comprises a support (e.g. beads) coated with a thin film of the catalyst
dissolved in water
or other polar solvent. The transfer hydrogenation phase is then effected by
providing the
support in the bulk organic phase (containing the hydrogen donor and the
substrate to be
2o hydrogenated) of the reaction. The base that is normally required for the
reaction may be
provided in either the film on the beads or dissolved in the bulk organic
phase.
Hydrogenated product will be produced in the bulk organic phase which, at the
end of the
reaction, may be decanted from the solid phase for recovery of the product.
This
procedure has the advantage of ensuring no or minimal catalyst residue in the
first
product.
As stated above, the catalyst incorporates at least one group R2° to
R22 or R~4 to
R2$ which is an optionally substituted sulphonated hydrocarbyl, sulphonated
perhalogenated hydrocarbyl or optionally substituted sulphonated heterocyclyl
group. The
catalyst may incorporate at least one further R2° to R22 or R24 to R2a
group in the form of
3o an optionally substituted hydrocarbyl, perhalogenated hydrocarbyl or
optionally substituted
heterocyclyl group, where the substituent(s) if present is/are other than
sulphonate
group(s). For convenience in the following description reference will be made
to the types
of hydrocarbyl, perhalogenated hydrocarbyl and heterocyclyl groups which may
be used
for Rz° to Rz2 or Rz4 to R2$ (as well as groups R'-"), it being
understood that the
sulphonated form of R2° to R22 or R~4to R28 may be a sulphonated form
of the rnoieties
described therefore.
The process of the invention effects hydrogenation of a carbon-carbon or
carbon-
heteroatom double bond in an organic compound. Examples of the heteroatoms
that may
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
4
form part of the double bond include oxygen, sulphur and nitrogen. Examples of
organic
compounds that may be hydrogenated by the process of the invention are of
formula I:
X
R~ ~ R2
(1 )
wherein:
X represents O, S, CR3R4, NRS, (NR6R')+Q-, N+R$-O-, (NR90R'°)+Q-,
NNR~~R'3,
NNR~aSO~R~6, NNR~2COR~', (NR~~NR'2R~s)+Q_~ (NR~~NR,zC(=NR'4)R~5)+Q-,
(NR"NR'zSO~R'6)+Q-, (NR"NR'2COR")+Q-, NP(O)R'SR'6, NS(O)R'S or NSO2R'S.
Q- represents a monovalent anion;
R', R2, R3, R4, R5, R6, R', R8, R9, R'°, R" R'2, R'3 and R'4 each
independently
to represents a hydrogen atom, an optionally substituted hydrocarbyl, a
perhalogenated
hydrocarbyl or an optionally substituted heterocyclyl group, one or more of R'
and Ra, R~
and R3, R' and R5, R' and R6, R' and R8, R' and R9, R' and R", R' and R'2, R2
and R4, R2
and R', R2 and R'°, R3 and R4, R6 and R', R9 and R'°, R" and
R'2, and R'2 and R'3
optionally being linked in such a way as to form an optionally substituted
ring(s); and R'S,
' R'6 and R" each independently represents an optionally substituted
hydrocarbyl, a
perhalogenated hydrocarbyl or an optionally substituted heterocyclyl group;
Hydrocarbyl groups which may be represented by R'-", R~°-a~ and
R~4-as
independently include alkyl, alkenyl and aryl groups, and any combination
thereof, such
as aralkyl and alkaryl, for example benzyl groups.
Alkyl groups which may be represented by R'-~', RZ°-~2 and R24-2e
include linear and
branched alkyl groups comprising up to 20 carbon atoms, particularly from 1 to
7 carbon
atoms and preferably from 1 to 5 carbon atoms. When the alkyl groups are
branched, the
groups often comprise up to 10 branched chain carbon atoms, preferably up to 4
branched chain atoms. In certain embodiments, the alkyl group may be cyclic,
commonly
comprising from 3 to 10 carbon atoms in the largest ring and optionally
featuring one or
more bridging rings. Examples of alkyl groups which may be represented by R'-
", Rio-2z
and R24-28 include methyl, ethyl, propyl, 2-propyl, butyl, 2-butyl, t-butyl
and cyclohexyl
groups.
Alkenyl groups which may be represented by R''", Rio-22 and R~4-28 include
C~_2o,
3o and preferably C2_6 alkenyl groups. One or more carbon - carbon double
bonds may be
present. The alkenyl group may carry one or more substituents, particularly
phenyl
substituents. Examples of alkenyl groups include vinyl, styryl and indenyl
groups. When
either of R' or R2 represents an alkenyl group, a carbon - carbon double bond
is
preferably located at the position ~i to the C=X moiety. When either of R' or
R~ represents
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
an alkenyl group, the compound of formula (1) is preferably an a,~-unsaturated
iminium
compound.
Aryl groups which may be represented by R'-", Rz°-zz and Rza-ze may
contain 1 ring
or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic
rings.
5 Examples of aryl groups which may be represented by R'-", Rz°-22 and
Rz4-za include
phenyl, tolyl, fluorophenyl, chlorophenyl, bromophenyl, trifluoromethylphenyl,
anisyl,
naphthyl and ferrocenyl groups.
Perhalogenated hydrocarbyl groups which may be represented by R'-", Rz°-
zz and
Rza-ze independently include perhalogenated alkyl and aryl groups, and any
combination
to thereof, such as aralkyl and alkaryl groups. Examples of perhalogenated
alkyl groups
which may be represented by R'-", Rzo-zz and Rza-ze include -CF3 and -C2F5.
Heterocyclic groups which may be represented by R'-", Rz°-zz and
Rza-zs
independently include aromatic, saturated and partially unsaturated ring
systems and may
constitute 1 ring or 2 or more fused rings which may include cycloalkyl, aryl
or heterocyclic
rings. The heterocyclic group will contain at least one heterocyclic ring, the
largest of
which will commonly comprise from 3 to 7 ring atoms in which at least one atom
is carbon
and at least one atom is any of N, O, S or P. When either of R' or Rz
represents or
comprises a heterocyclic group, the atom in R' or Rz bonded to the C=X group
is
preferably a carbon atom. Examples of heterocyclic groups which may be
represented by
2o R'-", Rz°-zz and Rza-ze include pyridyl, pyrimidyl, pyrrolyl,
thiophenyl, furanyl, indolyl,
quinolyl, isoquinolyl, imidazoyl and triazoyl groups.
When any of R'-", Rz°-zz and Rz4-z8 is a substituted hydrocarbyl or
heterocyclic
group, the substituent(s) should be such so as not to adversely affect the
rate or
stereoselectivety of the reaction. Optional substituents include halogen,
cyano, nitro,
hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogenated hydrocarbyl,
heterocyclyl,
hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters,
carbonates,
amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are
as
defined for R' above. One or more substituents may be present.
When any of R' and Rz, R' and R3, R' and R5, R' and R6, R' and R8, R' and R9,
R'
3o and R", R' and R'z, Rz and R4, Rz and R', Rz and R'°, R3 and R4, R6
and R', R9 and R'°,
R" and R'z, and R'z and R'3 are linked in such a way that when taken together
with either
the carbon atom and/or atom X of the compound of formula (1) that a ring is
formed, it is
preferred that these be 5, 6 or 7 membered rings. The rings formed in this way
may
additionally be fused to each other or to other ring systems. Examples of
rings which may
be so formed include:
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
6
x
N ~ S
X
N. C~~ CSC
N N
N N
~>
N
X
wherein X is as defined above and the rings may be optionally substituted or
may be
fused to other rings.
In certain preferred embodiments, R', Rz, R3, R4, R5, R6, R', R8, R9,
R'°, R", R~z
s R'3, R'4 R'S, R'6 and R" are all independently C~_6 alkyl or are a
combination of aryl,
particularly phenyl, C~_6 alkyl and C6_~oaralkyl. Substituents may be present,
particularly
substituents para to the C=X group when one or more of R~, Rz, R3, R4, R5, R6,
R', Ra, R9,
R~o~ R11' R1z' R13 ~ R14 R15 R~s and R" is a phenyl group.
In especially preferred embodiments, R4, R5, R6, or R$ are C~_6 alkyl or
C6_~oaralkyl,
1o especially methyl, benzyl or PhCHCH3.
Compounds of formula (1) where X is represented by NR5 or (NR6R')+Q', include
imines or iminium salts. Where a compound of formula (1) is an imine, it may
optionally
be converted to an iminium salt. Iminium salts are preferred over imines.
Preferred
iminium salts are represented by compounds of formula (1) in which X is
(NR6R')+Q' such
15 that either R6 or R' are hydrogen but that Rs and R' are not identical.
When the
compound of formula (1) is an iminium salt, an anion represented by Q' is
present.
Anions which may be represented by Q' include halides, optionally substituted
arylsulphonates, such as optionally substituted phenyl and napthyl
sulphonates, optionally
substituted alkylsulphonates including halogenated alkylsulphonates, such as
2o C,_zoalkylsulphonates, optionally substituted carboxylates, such as C~-10
alkyl and aryl
carboxylates, ions derived from the polyhalogenation of boron, phosphorous or
antimony,
and other common inorganic ions for example perchiorate. Examples of anions
which
may be present are bromide, chloride, iodide, hydrogen sulphate, tosylate,
formate,
acetate, tetrafluoroborate, hexafluorophosphate, hexafluoroantimonate,
perchlorate,
25 trifluoromethanesulphonate and trifluoroacetate. Preferred anions include
bromide,
chloride, iodide, formate and trifluoroacetate, particularly preferred anions
include iodide,
formate and trifluoroacetate.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
7
In certain preferred embodiments, X is a group of formula (NR6R')+Q- and R'
and
R6 are linked in such a way that when taken together with the carbon atom and
the
nitrogen atom of the C=X group of the compound of formula (1) that a 5, 6 or 7
membered
ring is formed, R' is C~_6 alkyl or C6_~oaralkyl, especially methyl, benzyl or
PhCHCH3, and
Rz is optionally substituted hydrocarbyl, preferably C~_s alkyl, or optionally
substituted
phenyl especially methoxy, hydroxy or fluoro substituted phenyl. The 5, 6 or 7
membered
ring formed by linking R' and R6 optionally may be fused to another ring
system,
preferably a benzenoid system which may be substituted, preferred substituents
include
hydroxy, methoxy and fluoro.
1o In certain preferred embodiments X is O so that the compound of the formula
(I) is
a ketone.
Most advantageously, the compound of formula (1) is prochiral, such that the
hydrogenated product comprises a chiral atom to which R', R2 and X are each
bonded.
Such an asymmetric transfer hydrogenation process forms an especially
preferred aspect
of the present invention. Most commonly, when the compound of formula (1) is
prochiral,
R' and RZ are different, and neither is hydrogen. Advantageously, one of R'
and R~ is
aliphatic and the other is aryl or heterocyclyl.
Examples of compounds of formula (1) include acetophenone, 4
chloroacetophenone, 4-methoxyacetophenone, 4-trifluoromethylacetophenone, 4
2o nitroacetophenone, 2-chloroacetophenone and acetophenone benzylimine.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
8
Further examples of compounds of formula (1) include:
G~
N+.-R~
N ~ ~ ~ ~ +'R2 ~N+~R~
Gz ~ / \R7 ~ ~ N
N/ 'R2
Rz Fi Rz
R~
7 7
R~I+ I ~ R~I+ I \ R~I+ I \
z / \ \ 2 /
\ ~R ~R
I ~ G, I / / /
G3
R\ + I / \ R~N' \
N I ~ I 1+
I \ Rz / / N \R~
wRz
Gt I ~ / Rz
N+~ R~ R~ R~ O' 1
N+.i N+ ~~
N\ ~~ S ~ N+
\ / \R~
R2 ' z ~z
Rz
G~ ~ O
Gz ~ N+~ Rz \N+~R
//O
Rz
wherein RZ and R' are as described above and G', G2 and G3 are independently
hydrogen, chloro, bromo, fluoro, iodo, cyano, nitro, hydroxy, amino, thiol,
acyl,
hydrocarbyl, perhalogenated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or
di-
hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and
sulphonamido groups wherein the hydrocarbyl groups are as defined for R'
above.
Hydrogen donors include hydrogen, primary and secondary alcohols, primary and
secondary amines, carboxylic acids and their esters and amine salts, readily
1o dehydrogenatable hydrocarbons, clean reducing agents, and any combination
thereof.
Primary and secondary alcohofs which may be employed as hydrogen donors
comprise commonly from 1 to 10 carbon atoms, preferably from 2 to 7 carbon
atoms, and
more preferably 3 or 4 carbon atoms. Examples of primary and secondary
alcohols which
may be represented as hydrogen donors include methanol, ethanol, propan-1-ol,
propan-
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
9
2-0l, butan-1-ol, butan-2-ol, cyclopentanol, cyclohexanol, benzylalcohol, and
menthol.
When the hydrogen donor is an alcohol, secondary alcohols are preferred,
especially
propan-2-of and butan-2-ol.
Primary and secondary amines which may be employed as hydrogen donors
comprise commonly from 1 to 20 carbon atoms, preferably from 2 to 14 carbon
atoms,
and more preferably 3 or 8 carbon atoms. Examples of primary and secondary
amines
which may be represented as hydrogen donors include ethylamine, propylamine,
isopropylamine, butylamine, isobutylamine, hexylamine, diethylamine,
dipropylamine, di
isopropylamine, dibutylamine, di-isobutylamine, dihexylamine, benzylamine,
1o dibenzylamine and piperidine. When the hydrogen donor is an amine, primary
amines are
preferred, especially primary amines comprising a secondary alkyl group,
particularly
isopropylamine and isobutylamine.
Carboxylic acids or their esfiers which may be employed as hydrogen donors
comprise commonly from 1 to 10 carbon atoms, preferably from 1 to 3 carbon
atoms. In
certain embodiments, the carboxylic acid is advantageously a beta-hydroxy-
carboxylic
acid. Esters may be derived from the carboxylic acid and a C~_~o alcohol.
Examples of
carboxylic acids which may be employed as hydrogen donors include formic acid,
lactic
acid, ascorbic acid and mandelic acid. The most preferred carboxylic acid is
formic acid.
In certain preferred embodiments, when a carboxylic acid is employed as
hydrogen donor,
2o at least some of the carboxylic acid is preferably present as salt,
preferably an amine,
ammonium or metal salt. Preferably, when a metal salt is present the metal is
selected
from the alkali or alkaline earth metals of the periodic table, and more
preferably is
selected from the group I elements, such as lithium, sodium or potassium.
Amines which
may be used to form such salts include both aromatic and non-aromatic amines,
also
primary, secondary and tertiary amines and comprise typically from 1 to 20
carbon atoms.
Tertiary amines, especially trialkylamines, are preferred. Examples of amines
which may
be used to form salts include trimethylamine, triethylamine, di-
isopropylethylamine and
pyridine. The most preferred amine is triethylamine. When at least some of the
carboxylic acid is present as an amine salt, particularly when a mixture of
formic acid and
3o triethylamine is employed, the mole ratio of acid to amine is between 1:1
and 50:1 and
preferably between 1:1 and 10:1, and most preferably about 5:2. When at least
some of
the carboxylic acid is present as a metal salt, particularly when a mixture of
formic acid
and a group I metal salt is employed, the mole ratio of acid to metal ions
present is
between 1:1 and 50:1 and preferably between 1:1 and 10:1, and most preferably
about
2:1. The ratios of acid to salts may be maintained during the course of the
reaction by the
addition of either component, but usually by the addition of the carboxylic
acid.
Readily dehydrogenatable hydrocarbons which may be employed as hydrogen
donors comprise hydrocarbons which have a propensity to aromatise or
hydrocarbons
which have a propensity to form highly conjugated systems. Examples of readily
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
dehydrogenatable hydrocarbons which may be employed by as hydrogen donors
include
cyclohexadiene, cyclohexene, tetralin, dihydrofuran and terpenes.
Clean reducing agents which may be represented as hydrogen donors comprise
reducing agents with a high reduction potential, particularly those having a
reduction
5 potential relative to the standard hydrogen electrode of greater than about -
0.1 eV, often
greater than about -0.5eV, and preferably greater than about -1 eV. Examples
of clean
reducing agents which may be represented as hydrogen donors include hydrazine
and
hydroxylamine.
The most preferred hydrogen donors are propan-2-ol, butan-2-ol,
to triethylammonium formate and a mixture of triethylammonium formate and
formic acid.
However, in certain embodiments when the compound of Formula (1) is a
protonated
imminium salt, it may be desirable to employ a hydrogen donor which is not a
carboxylic
acid or a salt thereof.
The optionally substituted hydrocarbyl or perhalogenated hydrocarbyl ligand
which
may be represented by R'$ includes optionally substituted aryl, alkenyl and
cyclopentadienyl ligands.
Optionally substituted aryl ligands which may be represented by R'8 may
contain 1
ring or 2 or more fused rings which include cycloalkyl, aryl or heterocyclic
rings. The
ligand may comprise a 6 membered aromatic ring. The ring or rings of the aryl
ligand are
often substituted with hydrocarbyl groups. The substitution pattern and the
number of
substituents will vary and may be influenced by the number of rings present,
but often
from 1 to 6 hydrocarbyl substituent groups are present, preferably 2, 3 or 6
hydrocarbyl
groups and more preferably 6 hydrocarbyl groups. Preferred hydrocarbyl
substituents
include methyl, ethyl, iso-propyl, menthyl, neomenthyl and phenyl.
Particularly when the
aryl ligand is a single ring, the ligand is preferably benzene or a
substituted benzene,
When the ligand is a' perhalogenated hydrocarbyl, preferably it is a
polyhalogenated
benzene such as hexachlorobenzene or hexafluorobenzne. When the hydrocarbyl
substituents contain enantiomeric and/or diastereomeric centres, it is
preferred that the
enantiomerically and/or diastereomerically purified forms of these are used.
Benzene, p-
3o cymyl, mesitylene and hexamethylbenzene are especially preferred ligands
having a 6
membered aromatic ring.
Optionally substituted alkenyl ligands which may be represented by R'$ include
C2-30, and preferably C5_~2, alkenes or cycloalkenes with preferably two or
more carbon-
carbon double bonds, preferably only two carbon-carbon double bonds. The
carbon-
carbon double bonds may optionally be conjugated to other unsaturated systems
which
may be present, but are preferably conjugated to each other. The alkenes or
cycloalkenes may be substituted preferably with hydrocarbyl substituents. When
the
alkene has only one double bond, the optionally substituted alkenyl ligand may
comprise
two separate alkenes. Preferred hydrocarbyl substituents include methyl,
ethyl, iso-propyl
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
11
and phenyl. Examples of optionally substituted alkenyl ligands include cyclo-
octa-1,5-
diene and 2,5-norbornadiene.
It is however particularly preferred that R'$ is an optionally substituted
cyclopentadienyl group.
Optionally substituted cyclopentadienyl group which may be represented by R'$
include particularly ones capable of eta-5 bonding. The cyclopentadienyl group
is often
substituted with from 1 to 5 hydrocarbyl groups, preferably with 3 to 5
hydrocarbyl groups
and more preferably with 5 hydrocarbyl groups. Preferred hydracarbyl
substituents
include methyl, ethyl and phenyl. When the hydrocarbyl substituents contain
enantiomeric
to and/or diastereomeric centres, it is preferred that the enantiomerically
and/or
diastereomerically purified forms of these are used. Examples of optionally
substituted
cyclopentadienyl groups include cyclopentadienyl, pentamethyl-
cyclopentadienyl,
pentaphenylcyclopentadienyl, tetraphenylcyclopentadienyl,
ethyltetramethylpentadienyl,
menthyltetraphenylcyclopentadienyl, neomenthyl-tetraphenylcyclopentadienyl,
menthylcyclopentadienyl, neomenthylcyclopentadienyl, tetrahydroindenyl,
menthyltetrahydroindenyl and neomenthyltetrahydroindenyl groups.
Pentamethylcyclopentadienyl is especially preferred.
It is particularly preferred that R'$ is an optionally substituted
cyclopentadienyl
group.
2o When either A or B is an amide group represented by -NR'9-, -NHR'9, NR'9RZo
-NR23-, -NHR23 or NR22R2s wherein R2° and R2' are as hereinbefore
defined, and where
R'9 or R23 is an acyl group represented by -C(O)R2' or -C(O)R24, R2' and R~4
independently are often linear or branched sulphonated C~_~alkyl, sulphonated
C~_$-
cycloalkyl or sulphonated aryl, for example sulphonated phenyl. Examples of
sulphonated
acyl groups which may be represented by R'9 or R~3 include sulphonated
benzoyl, acetyl
and halogenoacetyl groups.
When either A or B is present as a sulphonamide group represented by -NR'9-,
-NHR'9, NR'9R2°, -NR23-, -NHR23 or NRz2R~3 wherein R2° and R22
are as hereinbefore
defined, and where R'9 or R23 is a sulphonyl group represented by -S(O)ZR2' or
-S(O)2R2a,
3o R~' and R24 independently are often linear or branched sulphonated
C~_salkyl, sulphonated
C~_$cycloalkyl or sulphonated aryl, for example sulphonated phenyl. Preferred
sulphonyl
groups include sulphoanted derivatives of methanesulphonyl,
trifluoromethanesulphonyl
and especially phenylsulphonyl groups and naphthylsulphonyl groups.
When either of A or B is present as a group represented by -NR'9-, -NHR'9,
NR'9R2°, -NRa3-, -NHR23 or NR22Ra4 wherein Rz° and R23 are as
hereinbefore defined, and
where R'9 or R23 is a group represented by C(O)NR2'R25, C(S)NR~'RzS,
C(=NR25)SR2s,
C(=NR25)ORz6, C(O)NR24Ray C(S)NR24R2y C(=NR2')SR2$ or C(=NR~')OR28, R2' and
R~4
independently are often linear or branched sulphonated C~_8alkyl, such as
methyl, ethyl,
isopropyl, C~_scycloalkyl or sulphonated aryl, for example phenyl, groups and
R~2'25 are
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
12
often each independently hydrogen or linear or branched C~_$alkyl, such as
methyl, ethyl,
isopropyl, sulphonated C~_$cycloalkyl or aryl, for example phenyl, groups.
When B is present as a group represented by -OR22, -SRZ~, -PR22- or -PR22R~4,
R~2
and R24 independently are often linear or branched C~_$alkyl, such as methyl,
ethyl,
isopropyl, C~_scycloalkyl or aryl, for example phenyl.
It will be recognised that the precise nature of A and B will be determined by
whether A, and/or B are formally bonded to the metal or are coordinated to the
metal via a
lone pair of electrons.
It is particularly preferred in accordance with the invention that A is a
group of the
io formula -NHR'9 or -NR'9- where R'9 is represented by the group -S02R2' in
which R~' is
an optionally substituted sulphonated hydrocarbyl group, sulphonated
perhalogenated
hydrocarbyl group or optionally substituted sulphonated heterocyclyl group.
Most
preferably R2' is a sulphonated phenyl group having n sulphonate groups where
n is 1 to
5. When n is 1 to 4 the sulphonate groups may be present in any substitution
pattern on
the aromatic ring. In the particular case where n=1 then the sulphonate group
may be
ortho, meta or para to the sulphonamide group.
B is preferably-NHZ or -NH-.
The groups A and B are connected by a linking group E. The linking group E
achieves a suitable conformation of A and B so as to allow both A and B to
bond or
2o coordinate to the metal, M. A and B are commonly linked through 2, 3 or 4
atoms. The
atoms in E linking A and B may carry one or more substituents. The atoms in E,
especially the atoms alpha to A or B, may be linked to A and B, in such a way
as to form a
heterocyclic ring, preferably a saturated ring, and particularly a 5, 6 or 7-
membered ring.
Such a ring may be fused to one or more other rings. Often the atoms linking A
and B will
be carbon atoms. Preferably, one or more of the carbon atoms linking A and B
will carry
substituents in addition to A or B. Substituent groups include those which may
substitute
R', as defined above. Advantageously, any such substituent groups are selected
to be
groups which do not coordinate with the metal, M. Preferred substituents
include halogen,
cyano, nitro, sulphonyl, hydrocarbyl, perhalogenated hydrocarbyl and
heterocyclyl groups
3o as defined above. Most preferred substituents are C~_g alkyl groups, and
phenyl groups.
Most preferably, A and B are linked by two carbon atoms, and especially an
optionally
substituted ethyl moiety. When A and B are linked by two carbon atoms, the two
carbon
atoms linking A and B may comprise part of an aromatic or aliphatic cyclic
group,
particularly a 5, 6 or 7-membered ring. Such a ring may be fused to one or
more other
such rings. Particularly preferred are embodiments in which E represents a 2
carbon
atom separation and one or both of the carbon atoms carries an optionally
substituted aryl
group as defined above or E represents a 2 carbon atom separation which
comprises a
cyclopentane or cyclohexane ring, optionally fused to a phenyl ring.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
13
E preferably comprises part of a compound having at least one stereospecific
centre. Where any or all of the 2, 3 or 4 atoms linking A and B are
substituted so as to
define at least one stereospecific centre on one or more of these atoms, it is
preferred that
at least one of the stereospecific centres be located at the atom adjacent to
either group A
or B. When at least one such stereospecific centre is present, it is
advantageously
present in an enantiomerically purified state.
When B represents -O- or -OH, and the adjacent atom in E is carbon, it is
preferred that B does not form part of a carboxylic group.
Sulphonated compounds which may be represented by A-E-B, ar from which A-E
to B' may be derived by deprotonation, are often aminoalcohols or diamines in
which an or
the amino nitrogen atom has bound (directly or indirectly) thereto a
substituent
incorporating a group R2° to R~2 or R24 to R~8 in the form of an
optionally substituted
sulphonated hydrocarbyl group, a sulphonated perhalogenated hydrocarbyl group
or an
optionally substituted sulphonated heterocyclyl group. Examples of
aminoalcohols from
which said N-substituted compound may be derived including 4-aminoalkan-1-ols,
1-
aminoalkan-4-ols, 3-aminoalkan-1-ols, 1-aminoalkan-3-ols, and especially 2-
aminoalkan-
1-ols, 1-aminoalkan-2-ols, 3-aminoalkan-2-ols and 2-aminoalkan-3-ols, and
particularly 2-
aminoethanols or 3-aminopropanols. Further aminoalcohols are 2-
aminocyclopentanols
and 2-aminocyclohexanols, preferably fused to a phenyl ring. Examples of
diamines from
2o which said N-substituted compounds may be derived include 1,4-
diaminoalkanes, 1,3
diaminoalkanes, especially 1,2- or 2,3- diaminoalkanes and particularly
ethylenediamines.
Further diamines are 1,2-diaminocyclopentanes and 1,2-diaminocyclohexanes,
preferably
fused to a phenyl ring. The aminoalcohols or diamines are advantageously
substituted,
especially on the linking group, E, by at least one alkyl group, such as a
C~_4-alkyl, and
particularly a methyl, group or at least one aryl group, particularly a phenyl
group.
In summary it is particularly preferred that E has two carbon atoms linking A
and B,
one or both of these atoms being optionally substituted. In certain preferred
embodiments
E is of the formula -CHR3°-CHR3'- where R3° and R3' are
independently hydrogen or an
optionally substituted hydrocarbyl group.
3o In other preferred embodiments, E is a carbon-carbon bond that is part of
an
optionally substituted cycloaliphatic ring, preferably cyclopentyl or
cyclohexyl.
Examples of ligands from which compounds A-E-B may be derived are as follows:
R33 R34
O
W HN-SI-R3z
O
in which:
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
14
W is -OH or -NH2;
R3~ is an aryl group having at least one -S03H or S03M' (M'=alkali metal)
substituent and is further optionally substituted, e.g. with a carboxylic acid
group which
may, for example, be ortho to the -S03H or -SO3M' group and may lead to
anhydride
formulation therewith. More preferably R32 is a phenyl group having one -S03H
or -SO3M'
substituent; and
R33' Rs4 are independently optionally substituted hydrocarbyl groups or R33
and R34
are optionally linked in such a way as to define an optionally substituted
ring, more
preferably R33 and R34 are independently phenyl or R33 and R34 are linked so
as to define
to a cyclohexyl ring.
Specific examples of aminoalcohols and diamines from which the sulphonated
compounds A-E-B may be derived are:
Ph Ph Ph Ph
NHa HN-S-Ph NH2 HN-S-Naphthyl
O O
~yQ
NH-II Ph
O
Ph-S-NH
NHZ
NHy
I$
Advantageously, certain ligands are prepared by oxidative cleavage of the
corresponding di-sulphide.
Accordingly there is provided a process comprising reacting a di-sulphide of
formula:
R33 R34 R34 R33
O O
W HN-S-R35S-S-R35S-NH W
II II
20 O O
with an oxidant to produce a compound of formula:
R 33 R 34
~ 0
W HN-S-R3~
I I
O
wherein:
W is -OH or -NH2;
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
R32 is an aryl group having at feast one -S03H or S03M' (M'=alkali metal)
substituent;
R35 is an aryl group; and
R33' R3a are independently optionally substituted hydrocarbyl groups or R33
and R3a
5 are optionally linked in such a way as to define an optionally substituted
ring, more
preferably R33 and R34 are independently phenyl or R33 and R34 are linked so
as to define
a cyclohexyl ring.
Preferably the substitution pattern of the aryl group R32 is such that the -
S03H or
S03M' (M'=alkali metal) substituent is positioned para with respect to the
S02NH-CHR3a
l0 CHR33-W group. Corresponding a similar substitution pattern in R35 is
preferred.
Preferably the oxidant is alkaline hydrogen peroxide, particularly a mixture
is
sodium hydroxide solution and hydrogen peroxide solution.
Metals which may be represented by M include metals which are capable of
catalysing transfer hydrogenation. Preferred metals include transition metals,
more
15 preferably the metals in Group VIII of the Periodic Table, especially
ruthenium, rhodium or
iridium. When the metal is ruthenium it is preferably present in valence state
II. When the
metal is rhodium or iridium it is preferably present in valence state I.
Anionic groups ' which may be represented by Y include hydride, hydroxy,
hydrocarbyloxy, hydrocarbylamino and halogen groups. Preferably when a halogen
is
2o represented by Y, the halogen is chloride. When a hydrocarbyloxy or
hydrocarbylamino
group is represented by Y, the group may be derived from the deprotonation of
the
hydrogen donor utilised in the reaction.
Basic ligands which may be represented by Y include water, C~_4 alcohols, C~_$
primary or secondary amines, or the hydrogen donor which is present in the
reaction
system. A preferred basic ligand represented by Y is water.
Most preferably, the nature of A-E-B, R'$ and Y are chosen such that the
catalyst
is chiral. When such is the case, an enantiomerically and/or
diastereomerically purified
form is preferably employed. Such catalysts are most advantageously employed
in
asymmetric transfer hydrogenation processes. In many embodiments, the
chirality of the
3o catalyst is derived from the nature of A-E-B.
The process is carried out preferably in the presence of a base, especially
when Y
is not a vacant site. The pKa of the base is preferably at least 8.0,
especially at least 10Ø
Convenient bases are the hydroxides, alkoxides and carbonates of alkali
metals; tertiary
amines and quaternary ammonium compounds. Preferred bases are sodium 2-
propoxide
and triethylamine. When the hydrogen donor is not an acid, the quantity of
base used can
be up to 5.0, commonly up to 3.0, often up to 2.5 and especially in the range
1.0 to 3.5, by
moles of the catalyst. When the hydrogen donor is an acid, the catalyst may be
contacted
with a base prior to the introduction of the hydrogen donor. In such a case,
the mole ratio
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
16
of base to catalyst prior to the introduction of the hydrogen donor is often
from 1:1 to 3:1,
and preferably about 1:1.
Although gaseous hydrogen may be present, the process is normally operated in
the absence of gaseous hydrogen since it appears to be unnecessary.
Advantageously, the process is carried out in the substantial absence of
carbon
dioxide.
When the products) from dehydrogenation of the hydrogen donor is volatile, for
example boils at under 100°C, the removal of this volatile product is
preferred. The
removal can be accomplished by distillation preferably at less than
atmospheric pressure
to or by use of inert gas sparging. When reduced pressure distillation is
employed, the
pressure is often no more than 500 mmHg, commonly no more than 200 mmHg,
preferably in the range of from 5 to 100 mmHg, and most preferably from 10 to
80 mmHg.
When the products) from dehydrogenation of the hydrogen donor is a gaseous
material,
for example when formic acid is present as a hydrogen donor, the removal is
most
preferably accomplished by the use of inert gas sparging, with for example
nitrogen.
Suitably the process is carried out at temperatures in the range of from minus
78
to plus 150°C, preferably from minus 20 to plus 110°C and more
preferably from minus 5
to plus 60°C. The initial concentration of the substrate, a compound of
formula (1), is
suitably in the range 0.05 to 1.0 and, for convenient larger scale operation,
can be for
2o example up to 6.0 more especially 0.25 to 2.0, on a molar basis. The molar
ratio of the
substrate to catalyst is suitably no less than 50:1 and can be up to 50000:1,
preferably
between 100:1 and 5000:1 and more preferably between 200:1 and 2000:1. The
hydrogen donor is preferably employed in a molar excess over the substrate,
especially
from 5 to 20 fold or, if convenience permits, greater, for example up to 500
fold. After
2s reaction, the mixture is worked up by standard procedures.
During the reaction a solvent may be present, preferably a polar solvent, more
preferably a polar aprotic solvent, for example acetonitrile,
dimethylformamide or
dichloromethane. Conveniently, the hydrogen donor may be the solvent when the
hydrogen donor is liquid at the reaction temperature, or it may be used in
combination with
3o a diluent. Usually it is preferred to operate in substantial absence of
water, but water does
not appear to inhibit the reaction. If the hydrogen donor or the reaction
solvent is not
miscible with water and the desired product is water soluble, it may be
desirable to have
water present as a second phase extracting the product, pushing the
equilibrium and
preventing loss of product optical purity as the reaction proceeds. The
concentration of
3s substrate may be chosen to optimise reaction time, yield and enantiomeric
excess.
The catalytic species is believed to be substantially as represented in the
above
formula. It may be employed as an oligomer or metathesis product, on a solid
support or
may be generated in situ.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
17
The catalyst can be made by reacting a metal aryl or alkenyl halide complex
with a
compound of formula A-E-B as defined above or a protonated equivalent from
which it
may be derived, and, where Y represents a vacant site, reacting the product
thereof with a
base. The metal aryl or alkenyl, halide complex preferably has the formula
[MR'$Z2]2 when
M is ruthenium (II) and has the formula [MR'$Z]2 when M is iridium or rhodium
(I),
wherein R'$ is as defined above, and Z represents a halide, particularly
chloride.
For the preparation of the catalysts according to the present invention, a
solvent is
preferably present. Suitable reaction temperatures are in the range 0-
100°C, for example
20-70°C, often giving reaction times of 0.5-24.0 h. After reaction is
complete, the catalyst
to may if desired be isolated, but is more conveniently stored as the solution
or used soon
after preparation. The solution can contain the hydrogen donor and this, if a
secondary
alcohol, may be present in or used as the solvent for steps (a) and/or (b).
The preparation
and after-handling should preferably be under an inert atmosphere, and
particularly in
carbon dioxide and oxygen-free conditions.
The catalyst or catalyst solution is generally treated with base either just
prior to
use in a transfer hydrogenation reaction, or during use. This can be
accomplished by
adding base to the catalyst in solution, or to the compound of formula (1) in
solution, or by
addition to the transfer hydrogenation reaction.
Iminium salts can generally be obtained by known literature methods, for
example the
2o quaternisation of imines, such as by treatment of imines with alkylating
agents.
Transfer hydrogenation can be accomplished by transferring the solution of
catalyst to a
solution of substrate, a compound of general formula I. Alternatively a
solution of
substrate can be added to a solution of catalyst. Base may be pre-added to the
catalyst
solution and/or the substrate solution, or can be added later. The hydrogen
donor if not
already present in the catalyst solution may be added to the substrate
solution, or may be
added to the reaction mixture.
The invention is illustrated by the following Examples.
The invention will be illustrated by the following non-limiting Examples. For
convenience, the Examples are divided into two sections, viz a Ligand
Synthesis Section
3o in which Examples LS1-4 and LS18 describe the synthesis of various ligands
embraced
by the formula A-E-B described above and a "Catalyst Preparation and
Hydrogenation"
Section in which Examples TH5-17 and describe preparation of catalysts with
ligands as
synthesised in Examples LS1-4 and transfer hydrogenation reactions employing
these
catalysts. Example TH19 describes a transfer hydrogenation process wherein the
catalyst
is removed at he end of reaction by treatment with ion exchange resins.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
18
EXAMPLES
Example LS 1
Preparation of sodium (1S, 2S)-1,2-diphenylethylenediamine-N-phenylsulfonyl-4-
sulfonate (CB 3.016).
O
HZN ° HN-~~ . ~ ~ S03Na
O
::
CB3.016
(i) Synthesis of sodium 4,4'-dithiobisbenzenesulfonate. (CB3.011)
H2N ~ ~ S03H ~ Na03S ~ ~ S-S ~ ~ S03Na
2o Sodium 4,4'-dithiobisbenzenesulfonate (CB3.011) was synthesised following
the
protocol of Smith et. al (H.A Smith, G. Goughty, G Dorin j. Chem. Soc., 1964,
29, 1484-
1488) with some minor modifications. Sulfanilic acid (47.5 g, 0.25 mol) and
anhydrous
sodium carbonate were dissolved in water (500 ml) by warming. The solution was
cooled
to 15°C and sodium nitrite (18.5 g, 0.27 mol) in water (50 ml) was
added. The mixture
was poured slowly into conc. hydrochloric acid (52.5 ml, 0.64 mol) and crushed
ice (300 g)
and the resulting suspension was stirred for 15 minutes.
Sodium sulfide nonahydrate (65 g, 0.27 mol) and powdered sulfur (8.5 g, 0.27
mol) were
dissolved in water (75 ml) at 100°C. A solution of sodium hydroxide (10
g, 0.25 mol) in
water (100 ml) was added and the resulting disodium disulfide solution was
cooled to 0°C
(ice bath). The diazo solution was added over a period of 30 minutes, along
with 50 g of
ice to keep the temperature below 5°C. The ice bath was removed and the
reaction
mixture was allowed to come to room temperature. After 2 hours the evolution
of nitrogen
ceased and the reaction mixture was acidified to pH 2 by addition of conc.
hydrochloric
acid. The precipitated sulfur was filtered off and the solution was
concentrated by heating
on a stirrer hotplate to a volume of ca. 500 ml. After cooling to r.t. the
solution was
neutralised with sodium hydroxide solution (10% in water) and concentrated to
400 ml.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
19
The product crystalised after standing overnight at r.t. and was collected in
a buchner
funnel and dried under high vacuum. Yield 19.8 g (37.5%, 46.9 mmol). 'H NMR
(400
MHz, D20) d 7.36 (d, J=8.2 Hz, 4H), 7.53 (d, J=8.2 Hz, 4H); '3C NMR (100 MHz,
D20) d
126.47 (+), 127.04 (+), 140.07 (Cqua,~), 141.38 (Cquaft).
(ii) Synthesis of 4,4'-Disulfanediyl-bis-benzene sulfonyl chloride. (CB3.012)
Na03S ~ ~ S-S ~ ~ S03Na ---~ CI02S ~ ~ S-S ~ ~ S02CI
CB3.011 CB3.012
A flask (100 ml) with reflux condenser and a bubbler was charged with CB3.011
(10 g, 23.7 mmol), POCI3 (10 ml) and PCIS (5 g). The mixture was heated to
reflux for 2
1o hours (120°C oil bath temperature). After cooling to room
temperature temperative
dichloromethane (50 ml) was added and the resulting mixture was poured into
ice. After 1
hour of intensive stirring the organic layer was separated and stirred with
conc.
bicarbonate solution (100 ml) for another hour. The organic layer was
separated again,
dried over sodium sulfate and concentrated to a volume of ca. 25 ml. The
product was
precipitated by slow addition of cyclohexane with stirring, filtered off and
dried under high
vacuum. Yield 6.89 g (16.6 mmol, 70%). m.p. 139°C (LIt.Ref,:
142°C);'H NMR (400 MHz,
CDC13) d 7.69 (d, J=8.6 Hz, 4H), 7.98 (d, J=8.6 Hz, 4H); 13C NMR (100 MHz,
CDC13) d
126.69 (+), 128.08 (+), 143.03 (Cqua~), 145.05 (Cquaft); MS (+FAB(3-NBA)) m/e
413.9
(100, M).
(Ref 1: T. Zincke, W. Frohneberg Chem Ber., 1909, 42, 2721-2736)
(iii) Synthesis of (CB3.010)
o ~ o
s-s
CB3.010
To a solution of (S, S)-diphenylethylenediamine (3.73 g, 17.6 mmol) and
triethylamine (5 ml) in 50 ml of dichloromethane a solution of 4,4'-
Disulfanediyl-bis-
benzenesulfonyl chloride (CB3.012) (3.32 g, 8.0 mmol) in dichloromethane (10
ml) was
added slowly at 0°C (ice-bath). The reaction mixture was stirred for 12
hours at room
temperature and then concentrated under reduced pressure. The crude product
was
purified by chromatography on silica (first DCM, then DCM/methanol 25:1 as
eluent). The
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
product was obtained as a slightly yellow solid. Yield 5.65 g (7.37 mmol,
92%). m.p. 108-
110°C;'H NMR (400 MHz, CDCI3) d 4.16 (d, J=5.3 Hz, 2H), 4.44 (d, J=5.3
Hz, 2H), 7.07-
7.14 (m, 20H), 7.20 (d, J=8.8 Hz, 4H), 7.35 (d, J=8.8 Hz, 4H); ~3C NMR (100
MHz, CDCI3)
d 60.61 (+), 63.73 (+), 126.18 (+), 126.80 (+), 127.20 (+), 127.66 (+), 127.72
(+), 127.81
5 (+), 128.48 (+), 128.64 (+), 138.92 (Cquad), 139.29 (Cquad), 141.05 (Cqua~),
141.12
(Cqua~); MS (+FAB(3-NBA)) m/e 767 (47, M+1), 106 (100); [a]p20 _g7,0°
(c=1.31, EtOH).
(iv) Synthesis of sodium (1S, 2S)-1,2-diphenylethylenediamine-N-phenylsulfonyl-
4-
sulfonate (CB3.016).
n
S03Na
CB3.010 >
10 CB3.016
CB3.016: Sodium hydroxide solution (10 ml, 2.5M in water, 25 mmol) and
hydrogen peroxide solution (5 ml, 27.5% by weight in water) were added a
solution of
CB3.010 (4.82 g, 6.28 mmol) in methanol (50 ml). An exothermic reaction
resulted. The
15 resulting mixture was stirred for 2 hours before another 2 ml or hydrogen
peroxide solution
were added. Stirring at room temperature was continued for 12 hours, then
concentrated
sodium hydrogen sulfite solution was added (10 ml) and the mixture was stirred
for
another 2 hours. The reaction mixture was concentrated to dryness under
reduced
pressure, water (50 ml) was added to dissolve the inorganic salts and the
product was
2o filtered off. The product was washed with cold water (100 ml) and
dichloromethane (50
ml) and dried under high vacuum. Yield 4.454 g (10.3 mmol, 82%). m.p.
>280°C (dec.);
'H NMR (400 MHz, DMSO-d6) d 4.43 (d, J=10.4 Hz, 1 H), 4.65 (d, J=10.4 Hz, 1
H), 6.79-
6.93 (m, 5H), 7.19 (s, 5H), 7.41 (d, J=8.6 Hz, 2H), 7.45 (d, J=8.6 Hz, 2H),
8.61 (bs, 4H);
'3C NMR (100 MHz, DMSO-ds) d 59.24 (+), 62.10 (+), 126.35 (+), 126.72 (+),
128.25 (+),
128.39 (+), 128.93 (+)', 129.02 (+), 129.40 (+), 134.61 (Cauart), 136.14
(Cqua~), 141.05
(Cqua~), 152.03 (Cqua~); MS (FAB(3-NBA)) m/e 433.1 (93, M+1), 165.0 (100);
[a]p2o
-76.9° (c=1.3, DMSO).
Example LS2
3o Preparation of sodium (1 R, 2R)-1,2-diaminocyclohexyl-N-phenylsulfonyl-4-
sulfonate (CB3.019).
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
21
0
H2N HN-~~ ~ ~ S03Na
O
CB3.019
(i) Synthesis of CB 3.018.
0 0
a - - a
H2N HN-S ~ ~ S-S ~ ~ S-NH NH2
CB3.012 >
O O
CB3.018
1o To solution of (R, R)-1,2-diaminocyclohexane (1.76 g, 15.4 mmol) and
triethylamine
(5 ml) in 50 ml of dichloromethane was added slowly a solution of 4,4'-
Disulfanediyl-bis-
benzenesulfonyl chloride (CB3.012) (2.91 g, 7.0 mmol) in dichloromethane (10
ml) at
-78°C (acetone/dry ice bath). The reaction mixture was allowed to warm
up to room
temperature stirred for 12 hours at this temperature and then concentrated
under reduced
pressure. The crude product was purified by chromatography on silica (first
DCM, then
DCM/methanol 5:1 as eluent). The product was obtained as a slightly yellow
solid. Yield
3.44 g (6.02 mmol, 86%). m.p. 125-128°C; 'H NMR (400 MHz, CD3OD) d 1.01-
1.34 (m,
10H), 1.53-1.65 (m, 4H), 1.86-1.98 (m, 2H), 2.35-2.45 (m, 2H), 2.74-2.82 (m,
2H), 7.69 (d,
J=8.6 Hz, 4H), 7.84 (d, J=8.6 Hz, 4H); '3C NMR (100 MHz, CD30D) d 25.49 (-),
26.13 (-),
33.05 (-), 33.79 (-), 55.77 (+), 60.31 (+), 127.84 (+), 128.70 (+), 141.94
(Cqua~), 142.62
(Cqua~); MS (FAB(3-NBA)) m/e 571 (100, M+1); [a]p2° +36.5°
(c=2.0, EtOH).
(ii) Synthesis of sodium (1R, 2R)-1,2-diaminocyclohexyl-N-phenylsulfonyl-4-
sulfonate
(CB3.019).
0
83,018 ~ HZN HN-IS S03Na
O
::
CB3.019
Sodium hydroxide solution (4 ml, 1 M in water, 4 mmol) and hydrogen peroxide
solution (2 ml, 27.5% by weight in water) were added to a solution of CB3.018
(1.142 g,
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
22
2.0 mmol) in methanol (20 ml). An exothermic reaction ensued. The resulting
mixture
was stirred for 2 hours before another 2 ml hydrogen peroxide solution were
added.
Stirring at room temperature was continued for 12 hours, then concentrated
sodium
hydrogen sulfite solution was added (5 ml) and the mixture was stirred for
another 2
hours. The reaction mixture was concentrated to dryness under reduced
pressure, water
(20 ml) was added to dissolve the inorganic salts and the product was filtered
off. The
product was washed with cold water (40 ml), ethanol (20 ml), dichloromethane
(50 ml) and
dried under high vacuum. Yield 883 mg (2.64 mmol, 66%). m.p. >300°C; 'H
NMR (400
MHz, DMSO-d6) d 0.90-1.38 (m, 7H), 1.84-1.98 (m, 1 H), 2.66-2.82 (m, 1 H),
2.88-3.02 (m,
1 H), 7.82 (s, 4H), 7.89 (bs, 4H); 13C NMR (100 MHz, DMSO-d6) d 23.80 (-),
24.69 (-),
29.95 (-), 31.21 (-), 54.22 (+), 55.62 (+), 126.90 (+), 127.17 (+), 142.00
(Cqua~), 152.54
(Cqua~); MS (-FAB(3-NBA)) m/e 333 (100, M-1); [a]D2o +21.5° (c=1.7,
DMSO).
Example LS3
Preparation of sodium (1S, 2S)-1,2-diphenylethylenediamine-N- phenylsulfonyl-2-
sulfonate (3.022).
O
S\ (S,S)-DPEN
77%
n
CB3.022
Benzene-1,2-disulfonic acid anhydride (1.30 g, 5.9 mmol) was added to a
solution
of (S, S)-diphenylethylenediamine (1.25 g, 5.9 mmol) in 150 ml of
dichloromethane at room
temperature. The reaction mixture was stirred for 1 hour and then concentrated
under
reduced pressure. Isopropanol (50 ml) was added to the residue and the mixture
heated
to reflux for 15 minutes. After cooling to room temperature the product
precipitated and
was collected in a sinter-funnel and washed with isopropanol (50 ml). The
product is dried
3o under high vacuum at 60°C for 12 hours. Yield 1.96 g (4.54 mmol,
77%). m.p. >250°C;
'H NMR (400 MHz, d6-DMSO) d 4.60 (d, J=11.9 Hz, 1 H), 4.69 (dd, J=11.9, 8.2
Hz, 1 H),
6.71-6.79 (m, 5H), 7.12 (dt, J=7.8, 1.2 Hz, 1 H), 7.16-7.19 (m, 5H), 7.35 (dt,
J=7.8, 1.2 Hz,
1 H), 7.43 (dd, J=7.8, 1.2 Hz, 1 H), 7.43 (dd, J=7.8, 1.2 Hz, 1 H), 7.83 (dd,
J=7.8, 1.2 Hz,
1 H), 8.66 (s, 3H), 8.88 (d, J=8.2 Hz, 1 H).; 13C NMR (100 MHz, d6-DMSO) d
60.61 (+),
63.73 (+), 126.18 (+), 126.80 (+), 127.20 (+), 127.66 (+), 127.72 (+), 127.81
(+), 128.48
(+), 128.64 (+), 138.92 (Cqua~), 139.29 (Cquad), 141.05 (Cqua~), 141.12
(Cqua~); MS
(+FAB(3-NBA)) m/e 767 (47, M+1), 106 (100); [a]p20 _g7.0° (c=1.31,
EtOH).
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
23
Examale LS4
Synthesis of sodium (1R, 2R)-1,2-diphenylethylenediamine-N-phenylsulfonyl-4-
sulfonate (TT-CB4).
0
HZN , N-~ ~ / ~ SOaNa
O
TT-CB4
The preparation of TT-CB4 was undertaken in an identical manner to CB3.016
(Example LS1) but using R,R-diphenylethylenediamine in place of S,S-
diphenylethylenediamine.
1o Catalyst Preparation and H~idroaenation Section.
Unless' otherwise stated, the following procedures were employed for each of
Examples TH5 - TH19 below.
(a) Catalyst Preparation
In a Schlenk flask (25 ml) with a magnetic stirring-bar a solution of KOt-Bu
in
isopropanol (0.8 ml of a 0.1 M solution, 0.08 mmol) was added to a suspension
of ligand
(0.08mmol) in water (1 ml) and stirred under N2-atmosphere at room temperature
until a
clear solution was obtained. To this solution the transition metal compound
(0.01 mmol)
was added and the mixture stirred under an argon atmosphere at 40°C for
two hours.
(b) Hydrogenation
2o After cooling of the solution obtained in (i) to 22°C the substrate
to be
hydrogenated (2 mmol) in isopropanol (10 ml) and KOt-Bu in isopropanol (2.0 ml
of a 0.1
M solution, 0.20 mmol) were added to start the reaction.
Samples were taken out of the reaction mixture at~ various times and analysed
by
gas chromatography ([3-dex column).
The ligand, transition metal compound and hydrogenation substrate used are
tabulated below for each Example together with the results obtained in the
hydrogenation
reaction.
Example TH5
3o This Example demonstrates ruthenium catalysed asymmeteric transfer
hydrogenation of acetophenone in accordance with the equation:
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
24
OH
CH3 [RuCl2(p-cymene)]2 /CB3.016/ base ~ ~CH3
isopropanol
The reagents used were as follows
Transition Metal [RuCl2(p-cymene)]2 6.1 mg
Compound
Ligand CB3.016 34.6mg
Hydrogenation SubstrateAcetophenone 240mg
The results are shown in Table 1.
Table 1 Ruthenium/CB3.016/acetophenone. Hydrogenation at 22°C.
Time [h] T [C] Conversion ee [%]
[%]
3 22 16 95.0
20 22 61 95.3
28 22 74 95.3
44 22 96 94.4
Example TH6
to Example TH5 was repeated save that in step (a) stirring was effected at
22°C
(rather than at 40°C) and that step (b) was carried out at temperatures
of 22°C, 30°C and
40°C.
The results are shown in Tables 2 to 4.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
Table 2 Ruthenium/CB3.016/Acetophenone Hydrogenation at 22°C
Time [h] T [C] Conversion [%] ee [%]
1 22 3 -
2 22 7 -
3 22 10 -
4 22 13 -
16 22 39 96.3
25 22 51 95.3
41 22 58 96.3
69.5 22 62 96.0
Table 3 Ruthenium/CB3.016/Acetophenone at 30°C
Time [h] T [C] Conversion [%] ee [%]
1 30 10 95.0
2 30 19 -
3 30 26 -
4 30 34 95.7
16 30 68 95.2
25 30 73 95.5
41 30 77 95.1
69.5 30 77 94.2
Table 4 Ruthenium/CB3.016/Acetophenone at 40°C
Time [h] T [C] Conversion ee [%]
[%]
1 40 31 95.2
2 40 48 94.4
3 40 58 95.6
4 40 66 94.6
16 40 89 94.2
25 40 90 93.7
41 40 92 93.5
69.5 I 40 91 93.4
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
26
The temperature-effect is significant, but in all cases a slowdown or
standstill of
the reaction after about 20 h was observed, probably due to precipitation of
the catalyst.
The drop in enantioselectivity was not as high as expected.
Example TH7
This Example demonstrates the rhodium catalysed transfer hydrogenation of
acetophenone using CB3.016 as a ligand for the catalyst.
The following reactants were employed.
Transition Metal Compound 'Rh(Cp*)Clz]z
Ligand CB3.016
Hydrogenation Substrate Acetophenone
to
' [Rh(pentamethylcyclodienyl)Clz]z
The results obtained are shown in Table 5.
Table 5 Rhodium/CB3.016/Acetophenone
Time [h] T [C] Conversion ee [%]
[%]
1 22 34 97
18 22 72 97
Example TH8
This Example demonstrates the ruthenium catalysed transfer hydrogenation of
acetophenone using CB3.019 as catalyst ligand.
2o The following reactants were used.
Transition Metal Compound [RuClz(p-cymene)]z
Ligand CB3.019
Hydrogenation Substrate Acetophenone
The results are shown in Table 6
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
27
Table 6 Ruthenium/CB3.019/Acetophenone
Time [h] Conversion [%] ee [%]
1 ~1 -
19.5 28 88.0
28 40 90.7
51 54 90.8
96 67 89.8
Examale TH9
s This Example demonstrates the rhodium catalysed transfer hydrogenation of
acetophenone using CB3.019 as catalyst ligand.
The following reactants were used.
Transition Metal Compound [Rh(Cp*)Clz]z
Ligand CB3.019
Hydrogenation Substrate Acetophenone
to The results are shown in Table 7
Table 7 Rhodium/CB3.019/Acetophenone.
Time [h] Conversion [%] ee [%]
1 62 97.6
19.5 94 94.9
28 94 94.5
51 94 94.6
96 - ~ 96 94.5
Comparing the results of Examples TH8 and TH9, the rhodium-catalysed system
15 proved to be more reactive and selective compared to the ruthenium one. The
enantioselectivity was close to 98% after 1 h and dropped slightly at the end
to 94.5%.
Examale TH10
This Example investigates the use of a catalysts based on ruthenium and either
2o CB3.016, CB3.019 or CB.022 in the hydrogenation of a range of aromatic
ketones as
hydrogenation substrate. The hydrogenation procedure used was as described
previously
save that 1 cm3 of water was added additionally to the isopropanol and KOt-By.
The water
concentration was thus 15%.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
28
The following reactants were used
Transition Metal Compound [RuCl2(p-cymene)]2
Ligand (1) CB3.016
Ligand (2) CB-3.019
Ligand (3) CB3.022
Hydrogenation Substrate (5)-(10) See below
CH a ~ ~ CH s ~ ~ CH s ~ ~ CH a
FaC ~ / CFa
CFs
6 , 7 8
CHa \ ~ ~ CHa
Me0
5 The results are shown in Table 8.
Table 8 Ruthenium/CB3.016(1) or CB3.019(2) or CB3.022(3)/Ketones (5)-(10).
Ketone Ligand Reaction Conversion Ee [%]
time [%]
[h]
5 1 48 96 94
5 2 48 91 88
5 3 48 11 91
6 1 4 100 81
6 2 4 100 88
7 1 24 90 87
7 2 24 91 81
8 1 18 10 24
8 2 18 18 55
9 1 42 31 91
9 2 42 35 83
10 1 72 94 95
10 2 48 87 90
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
29
Example TH11
Example TH10 was repeated but using [Rh(Cp*)CI2]2 as the transition metal
compound. Thus, the reactants were as follows:
Transition Metal Compound [Rh(Cp*)CI2]a
Ligand (1) TT-CB4
Ligand (2) CB3.019
Hydrogenation Substrate (5)-(10) See above
The results are shown in Table 9.
Table 9 Rhodium/TT-CB4(1) or CB3.019(2)/Ketones(5)-(10)
Ketone Ligand Reaction Conversion ee [%]
time [%]
[h]
5 1 24 92 97
5 2 18 94 95
6 1 4 100 83
6 2 2 100 88
7 1 18 98 95
7 2 4 99 94
8 ~ 1 18 2 22
8 2 18 40 76
9 1 42 9 94
9 2 42 65 95
1 64 81 82
10 2 48 95 96
1o The results in tables 8 and 9 show the effectiveness of TT-CB4 and CB3.019
in
transfer hydrogenations. p-Trifluoromethyl acetophenone (6) reacts rapidly and
quantitatively giving moderate and very similar ee's in the ruthenium and
rhodium
catalysed reaction. m-Trifluoromethyl acetophenone (7) reacts slightly more
slowly giving
a very high ee only in the rhodium catalysed reaction. o-Trifluoromethyl
acetophenone (8)
reacts very slowly, compared to (6) and (7). Only the rhodium-catalysed
reaction using
ligand (2) shows moderate enantioselectivity. The electron-rich p-methoxy
acetophenone
(9) reacts relatively slowly, as expected. It was not possible to obtain a
conversion above
65% under these conditions. 2-Acetylnaphthalene (10) reacts similarly to
acetophenone.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
Examale TH12
The Example demonstrates the ruthenium catalysed transfer hydrogenation of
acetophenone using TT-CB4 as catalyst ligand.
Trarisition Metal Compound [RuCl2(p-cymene)]~
Ligand TT-CB4
Hydrogeneration Substrate Acetophenone
5
The results are shown in Table 10.
Table 10. Ruthenium/TT-CB4/Acetophenone
Reaction Time (hours)Conversion *(%) Enantiomeric excess
(%)
19 30 94.4
24.5 34 95.0
42.5 46 94.4
49 48 94.2
66 55 94.4
73 ~ 58 94.3
90 62 94.4
96 64 94.4
to Example TH13
Example TH12 was repeated using 4-Bromoacetophenone as hydrogenation
substrate in place of acetophenone.
The following reactants were employed.
Transition Metal Compound [RuCl2(p-cymene)]2
Ligand TT-CB4
Hydrogenation Substrate 4-Bromoacetophenone
The results are shown in Table 11
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
31
Table 11. Ruthenium/TT-CB4/4-Bromoacetophenone
Reaction Time (hours)Conversion (%) Enantiomeric excess
(%)
20.5 43 92.4
27 51 92.4
44 67 92.3
50.5 73 92.4
67.5 82 92.3
73.5 85 92.3
139 98 92.1
Example TH14
s Example TH13 was repeated but using 2-Fluoroacetophenone as hydrogenation
substrate.
The following reactants were employed.
Transition Metal Compound [RuCl2(p-cymene)]2
Ligand TT-CB4
Hydrogenation Substrate 2-Fluoroacetophenone
to The results are shown in Table 12.
Table 12: Ruthenium/TT-CB4/2-Fluooacetophenone
Reaction Time (hours)Conversion (%) Enantiomeric excess
(%)
2 7 73.3
19 41 75.1
26 48 75.1
43 64 75.0
48.5 69 75.3
114.5 91 75.2
Comparing the results of Examples TH12 to TH14, it can be seen that the rates
of
is ~ these reactions are generally quite low. However, the presence of an
electron-
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
32
withdrawing group 2-fluoroacetophenone increases the rate of reaction. The
enantioselectivities are high except in the case of the reduction of 2-
fluoroacetophenone.
This result is not surprising given that the fluoro substituent is in the
ortho position. It can
also be seen that the enantiomeric excess does not decrease over time as would
be
expected.
Example TH15
This Example describes the iridium catalysed hydrogenation of acetophenone
using TT-CB4 as catalyst ligand. The hydrogenation procedure used was the same
as
to that of Example TH10 (15% water)
The following reactants were employed.
Transition Metal Compound '[Ir(Cp*)CI2]a
Ligand TT-CB4
Hydrogenation Substrate (a)-(k) See below
'[Ir(pentamethylcyclopentadienyl)~CI2]~
0 0 o a o
R / / R
R
a: R=H c: R=Cl e: R=F .1 k
b: R=F d: R=Br f R=Br
h: R=CF3
i: R=OMe g: R=Cl
IS
The results are shown in Table 13.
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
33
Table 13. Iridium/TT-CB4/ketones (a)-(k)
Ketone Reaction Time Conversion (%) Ee (%)
(h)
a 140 90 82
b 51 83 85
c 91 89 76
d 91 93 76
a 68 86 36
F 163 65 29
G 163 89 24
. H 43 95 86
I 150 ~ 22 78
J 139 41 91
-~ _ ~7 ~ 73
_
139 -
Example TH16
Example TH15 was repeated but using CB-3.019 as ligand in place of TT-CB4.
The following reactants were employed.
Transition Metal Compound [Ir(Cp*)Cl2jz
Ligand CB-3.0_19
LHydrogenation Substrate I Ketones (a)-(k)
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
34
The results are.shown in Table 14
Table 14. Iridium/CB-3.019/ketones (a)-(k).
Ketone Reaction Time Conversion (5) ee(%)
(h)
a 26 88 96
b 26 99 94
c 25 98 94
d 20 99 95
a 21 99 73
f 92 95 66
g 46 - 96 63
h 4 98 93
i 141 80 95
j 45 55 97
- ~ 45 6 ~ ,96
There are noticeable differences in the results obtained for ruthenium and
iridium
with ligand 1 (TT-CB4). Generally, the ruthenium system gives rise to higher
enantiomeric
excess and lower reaction rate, whereas the iridium system gives a higher
reaction rate
and a lower enantiomeric excess. However, the combination of iridium and
ligand 2
proved to be most successful. The reactions tended to proceed rapidly with
high
1o enantioselectivity. For all systems, electron deficient ketones were
reduced more quickly.
This is best illustrated by comparing the results of the reduction of 3-
trifluoromethylacetophenone and 4-methoxyacetophenone. Also, as expected,
substrates
with ortho-groups gave rise to a lower reactivity and enantiomeric excess.
Example TH17
In order to determine the effect of an increase in water concentration, the
procedures of Examples TH14 and 15 were repeated but using a 2-propanol-water
mixture containing (i) 34% and (ii) 51 % water. The overall volume of reaction
solvent
remained unchanged.
The following reactants were employed.
Transition Metal Compound [Ir(Cp')CI2]2
Ligand (1) TT-CB4
Ligand (2) CB-3.019
Hydrogenation Substrate Ketones (a)-(k)
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
The results are shown in Table 15.
Table 15 Iridium/TT-CB4(1) or CB3.019(2)/Ketones (a)-(k)
Ketone Ligand Reaction Conversion ee(%)
Time(h) (%)
b' 1 22 74 92
b" 1 22 90 92
b' 2 2.5 82 94
b" 2 2.5 94 93
e" 2 5 97 74
i' 1 115 20 84
i" 1 115 33 91
i' 2 116 76 92
i" 2 116 89 87
k' 1 42 47 91
k" 1 42 66 93
k' 2 18 92 95
k" 2 18 92 94
Table 3. Iridium systems containing (i) 34% and (ii) 51 % water.
5 The results shown in Table 15 are surprising in that in expecfied rate
decrease
relating to the lower concentration of 2-propanol was not observed. Instead, a
significant
rate increase was noted for both the (i) 34% and (ii) 51 % water systems. In
addition to
this, iridium-ligand 1 systems showed a large increase in enantiomeric excess
when the
concentration of water was increased form 15% to 34% (see F results shown in
Table
10 13.).
Example LS18
This Example demonstrates the synthesis of a further ligand:
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
36
0
s
s~
DCM, reflux, 12 hours I clilorosulfonic acid
1 O
CIOzS
\S
S/
HZN NHZ
DCM
stir,
rt
HZN HN-S
I ~S
s
(i) NaOH, H202 I (ii) NaHSO3
stir, 12 h, rt
O O O
HzN HN-S COaH HzN HN-S
10 / I . i0 / I S
or
S03H ~ ~ \ O
O
Examale TH19
5 Bis-3,5-trifluoromethylacetophenone (1.32g, 5.16mmoles),
dichloro(pentamethylcyclopentadienyl)rhodium(III) dimmer
(7.4mg,11.97micromoles),
sodium (1 S,2S) 4-(2-Amino-1,2-diphenyl-ethylsulfamoyl)-benzenesulfonate
(11.2mg,
25.92micromoles), and 2.5m1 tetrahydrofuran were charged to a 25m1 flask and
flushed
with nitrogeri. Water (12microlitres, 0.66mmoles) was added by syringe and the
mixture
CA 02430295 2003-05-29
WO 02/44111 PCT/GBO1/05285
37
was stirred for 20minutes. A 2:5 molar ratio mixture of triethylamine and
formic acid were
added to the reaction at a rate of 1.5m1/h for 2h. At this time all the ketone
had been
converted to alcohol and the optical purity was determined to be 81 % ee. The
reaction
was concentrated by vacuum distillation a sample A was taken for Rhodium
analysis. To
the concentrate, 3m1 toluene and 5m1 water was added, the aqueous phase
separated
and the organic layer divided into three portions B, C, D of 1 ml. To each
portion was
added 1.6m1 water. Sample B was concentrated to dryness. To sample C 100mg of
AmberIiteT"" IRA-93 was added and the mixture stirred for 2 hours, filtered
and the filtrate
concentrated to dryness. To sample D 100mg of DowexT"" 1 x8-50 was added and
the
1o mixture stirred for 2 hours, filtered and the filtrate concentrated to
dryness. !n sample B
the concentrated filtrate was dark purple, whilst in samples C and D it was a
light pink.
The samples were analysed by ICPMS for Rhodium and the following results were
obtained:
Sample A 4930ppm
Sample B 1040ppm
Sample C 365ppm
Sample D 280ppm
2o The results from the analysis of Samples C and D compared to Sample B show
that treatment of the reaction mixture with ion exchange resins is effective
in the
separation of the catalyst from the reaction mixture.
